Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds B of A Securities Upgrades Flowserve to Neutral

B of A Securities Upgrades Flowserve to Neutral

B of A Securities analyst Andrew Obin upgrades Flowserve (NYSE:FLS) from Underperform to Neutral.

byBenzinga Newsdesk

July 11, 2022

1 minute read

B of A Securities analyst Andrew Obin upgrades Flowserve (NYSE:FLS) from Underperform to Neutral.

Analyst Ratings

Analyst Ratings for Xenon Pharmaceuticals

By Benzinga Insights

August 29, 9:27 AM

Xenon Pharmaceuticals (NASDAQ:XENE) has observed the following analyst ratings within the last quarter:

XENE

Natera Announces Significant Milestone with 200+ Peer-Reviewed Publications Highlighting Natera’s Technology In The Scientific Literature.

By Benzinga Newsdesk

April 22, 8:08 AM

Demonstrates commitment to generating real-world clinical evidence to change disease management and improve patient outcomesNatera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today

NTRA

Needham Maintains Buy on Airbnb, Lowers Price Target to $150

By Benzinga Newsdesk

August 3, 6:33 AM

Needham analyst Bernie McTernan maintains Airbnb (NASDAQ:ABNB) with a Buy and lowers the price target from $220 to $150.

ABNB

Walmart Under Fire: EEOC Lawsuit Accuses Retail Giant Of Ignoring Female Harassment Claims

By Nabaparna Bhattacharya

September 20, 11:17 AM

Walmart Inc. (NYSE: WMT) lands in the hot seat as the U.S.

WMT

B of A Securities Upgrades Flowserve to Neutral

Related Posts

Analyst Ratings for Xenon Pharmaceuticals

Natera Announces Significant Milestone with 200+ Peer-Reviewed Publications Highlighting Natera’s Technology In The Scientific Literature.

Needham Maintains Buy on Airbnb, Lowers Price Target to $150

Walmart Under Fire: EEOC Lawsuit Accuses Retail Giant Of Ignoring Female Harassment Claims